Alkaline Phosphatase

The Alkaline Phosphatase blood test measures the concentration of alkaline phosphatase, commonly abbreviated to ALP, in the bloodstream.

ALP is an enzyme produced in several tissues throughout the body. Two of its most clinically important sources are the liver and bile ducts and bone, although smaller amounts can also originate from the intestine and, during pregnancy, the placenta.

The test contains 1 biomarker: Alkaline Phosphatase. It is commonly included within liver and bone profiles because changes in ALP can provide useful clues about hepatobiliary function, bile flow and bone turnover.

A raised ALP result can occur when cells lining the bile ducts produce increased amounts of the enzyme, which is why ALP is frequently assessed when cholestasis or biliary obstruction is being investigated. However, ALP is not a liver-specific enzyme. Bone-forming cells called osteoblasts also produce ALP, and concentrations can increase when bone turnover is elevated.

This distinction matters. A raised result does not automatically mean there is a liver problem. Children and adolescents can have naturally higher ALP because of active skeletal growth, while pregnancy can raise ALP because of placental production. Healing fractures and several disorders affecting bone metabolism can also increase the result.

Other blood tests can provide additional context. Gamma-Glutamyltransferase (GGT) is often useful when trying to determine whether an elevated ALP is more likely to have a hepatobiliary origin. Calcium, Phosphate, Vitamin D and Parathyroid Hormone may provide complementary information where a bone-related source is suspected.

A low ALP result can also occasionally be clinically relevant, although isolated mildly low results are often less specific. Nutritional factors, certain endocrine conditions, medication and uncommon inherited disorders can influence ALP concentrations.

The Alkaline Phosphatase test therefore provides useful biochemical information but does not independently diagnose a liver, bile duct or bone condition. Interpretation should consider your age, symptoms, medication, pregnancy status where relevant, previous results and other laboratory findings.

The expected turnaround time for the Alkaline Phosphatase test is approximately 1 business day after your sample arrives at the laboratory.

Your result is sent securely by email once laboratory analysis and authorisation are complete. Turnaround therefore generally begins when the laboratory receives your blood sample rather than necessarily from the time it is collected.

Routine ALP analysis is usually completed quickly, although repeat analysis, laboratory quality-control requirements or sample-related issues can occasionally extend the expected turnaround.

Your laboratory report will show your Alkaline Phosphatase concentration together with the reference range used by the analysing laboratory.

A raised ALP result means more alkaline phosphatase activity has been detected than expected for the relevant laboratory reference range. The next question is usually where the additional enzyme is coming from.

When ALP is raised alongside Gamma-Glutamyltransferase (GGT) or other compatible liver abnormalities, a liver or biliary source may become more likely. Conditions affecting bile flow can produce substantial increases in ALP, but the blood test alone cannot identify the exact cause or location of an obstruction.

Where ALP is elevated but GGT and other liver markers are not similarly raised, a clinician may consider whether the source could be bone. Calcium, Phosphate, Vitamin D, Parathyroid Hormone and other bone-related investigations may then provide additional information depending on the clinical picture.

If the tissue source remains uncertain, Alkaline Phosphatase Isoenzymes testing can sometimes separate the different forms of ALP and help determine whether the predominant contribution is from liver, bone, intestine or another source.

Physiological factors must also be considered. Higher ALP concentrations can be normal during periods of rapid skeletal growth in children and adolescents. Pregnancy, particularly later pregnancy, can also increase ALP because of placental production.

A low ALP result is generally less common. Persistently low concentrations may occur with nutritional deficiency, hypothyroidism and some other conditions, while very low ALP can be relevant in rare inherited disorders such as hypophosphatasia. A single mildly low measurement does not diagnose any of these conditions.

Reference ranges vary according to laboratory method, age and sometimes sex or physiological status. A value should therefore always be compared with the reference interval provided on your own laboratory report.

Most importantly, an abnormal ALP result is not a diagnosis. It is a biochemical clue that helps determine whether further liver, biliary, bone or nutritional investigation may be appropriate.

London Blood Tests provides the Alkaline Phosphatase blood test in London for people who require targeted measurement of ALP as part of a liver, bile duct, bone or general biochemical assessment.

The test costs £36 and measures one biomarker: Alkaline Phosphatase. It can be useful when following a previous abnormal result, investigating liver or biliary abnormalities or assessing whether altered bone turnover may be contributing to a biochemical pattern.

Clinic appointments are available alongside home and hotel phlebotomy depending on location and availability, providing flexible access for people searching for a private ALP blood test in London.

Because total ALP can originate from several different tissues, an abnormal result should not be interpreted independently. Depending on the pattern, GGT and other Liver Function Tests, Vitamin D and mineral markers or specialist ALP isoenzyme testing may be considered.